Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

NCT06899789 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.

NCT NCT06899789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06899789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase
Observational
Overall status
Recruiting
Start date
July 29, 2022
Completion date
December 31, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced melanoma skin cancer, non-small cell lung carcinoma, kidney adenocarcinoma, ileo-colitis, immune checkpoint inhibitors-induced colitis, immune mediated-colitis